Latest Headlines

  1. Ferris State's College Of Pharmacy And College Of Engineering Tech Collaborate To Fulfill Lab Equipment Needs, Help Solve Practical Problems 8/3/2026

    Ferris State University is embodying campus collaboration as the College of Pharmacy and the College of Engineering Technology found a solution to laboratory equipment needs.

  2. Cizzle Bio Expands Access To Early Lung Cancer Detection Through Strategic Laboratory Collaboration With BioBridge Global In South Texas 8/3/2026

    Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, today announced that it has executed a strategic laboratory agreement with BioBridge Global (BBG), a San Antonio-based healthcare services organization with expertise in laboratory medicine, biomanufacturing, blood banking and translational science.

  3. Laboratory Basics For High-Consequence Infectious Diseases: Safe Testing Starts With Preparation 8/3/2026

    When caring for patients with suspected high-consequence infectious diseases (HCIDs) such as Ebola, Lassa fever, Marburg virus disease, or Middle East respiratory syndrome (MERS), timely laboratory testing is essential—but it must also be performed safely. 

  4. GenomOncology Announces Integrated End-To-End Workflow Using Pacbio's Long-Read Whole-Genome Sequencing Technology In Oncology 7/30/2026

    GenomOncology (GO), a precision oncology software company specializing in genomic data interpretation and reporting, today announced an end-to-end workflow for somatic whole-genome sequencing (WGS) in oncology.

  5. Roche Announces Partnership With Ivy Tech To Help Strengthen Indiana's Medical Laboratory Workforce 7/30/2026

    Roche Diagnostics North America today announced a strategic collaboration with Ivy Tech Community College to help address critical workforce shortages in medical laboratory technology through a phased workforce development initiative.

  6. Hilleman Laboratories To Develop And Produce CEPI-Backed Bundibugyo Ebolavirus Vaccine Doses For Clinical Trials 7/30/2026

    The Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singapore-based joint venture of biopharmaceutical company MSD and charitable foundation Wellcome, to advance the development and manufacturing of Bundibugyo ebolavirus vaccine candidate doses for clinical trials using the recombinant vesicular stomatitis virus (rVSV) platform.

  7. Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits For Analytical Studies 7/28/2026

    Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the Company's joint venture in India, has sent test kits of the SARAGENE® Bundibugyo Virus Test to a third-party laboratory for evaluation following a request by the India Centre for Cellular and Molecular Platforms ("C-CAMP"), an initiative supported by the India Department of Biotechnology.

  8. Ozelle Launches O-Cyte 1 At ADLM 2026, Marking A New Step In AI-Powered Hematology 7/28/2026

    Ozelle has officially launched O-Cyte 1, its newest automated hematology analyzer, at ADLM 2026 in Anaheim, California. Built on AI × CBM (Complete Blood Morphology), O-Cyte 1 marks an important step in Ozelle's vision for the 4th Generation of Hematology Analysis, combining morphology intelligence, productivity, and operational simplicity in a compact hematology system.

  9. New Blood Test For Tuberculosis Could Reduce The Spread Of This Top Global Infectious-Disease Killer 7/28/2026

    A new study presented today at ADLM 2026 in Anaheim, California found that a simple blood test could accurately identify tuberculosis (TB) — a leading cause of death worldwide — among patients with varying degrees of exposure to the disease. If confirmed, these results could help save millions of lives and curtail a global health emergency.

  10. Clinisys Partners With Decisions To Bring Low-Code / No-Code LIMS/LIS Configuration To Laboratory Environments 7/28/2026

    Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform.